The Valley Desk

NCT01107886 · Interventional trial

Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications

Overall registry status Completed

Phase 4

Conditions Type 2 Diabetes Mellitus

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov